Castle Rock Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,942
| Closed | -$284K | – | 248 |
|
|
2025
Q1 | $284K | Buy |
3,942
+15
| +0.4% | +$1.08K | 0.08% | 193 |
|
|
2024
Q4 | $299K | Sell |
3,927
-98
| -2% | -$7.47K | 0.07% | 191 |
|
|
2024
Q3 | $259K | Sell |
4,025
-2,230
| -36% | -$144K | 0.06% | 217 |
|
|
2024
Q2 | $565K | Buy |
6,255
+21
| +0.3% | +$1.9K | 0.14% | 140 |
|
|
2024
Q1 | $526K | Buy |
6,234
+192
| +3% | +$16.2K | 0.14% | 144 |
|
|
2023
Q4 | $439K | Buy |
6,042
+1,470
| +32% | +$107K | 0.13% | 150 |
|
|
2023
Q3 | $337K | Buy |
4,572
+207
| +5% | +$15.3K | 0.11% | 158 |
|
|
2023
Q2 | $397K | Sell |
4,365
-6
| -0.1% | -$546 | 0.14% | 141 |
|
|
2023
Q1 | $388K | Sell |
4,371
-582
| -12% | -$51.6K | 0.14% | 144 |
|
|
2022
Q4 | $387K | Buy |
4,953
+666
| +16% | +$52.1K | 0.17% | 145 |
|
|
2022
Q3 | $352K | Buy |
4,287
+27
| +0.6% | +$2.22K | 0.18% | 146 |
|
|
2022
Q2 | $419K | Sell |
4,260
-730
| -15% | -$71.8K | 0.21% | 125 |
|
|
2022
Q1 | $621K | Buy |
4,990
+1,286
| +35% | +$160K | 0.29% | 104 |
|
|
2021
Q4 | $417K | Buy |
3,704
+260
| +8% | +$29.3K | 0.17% | 154 |
|
|
2021
Q3 | $412K | Sell |
3,444
-2
| -0.1% | -$239 | 0.14% | 169 |
|
|
2021
Q2 | $386K | Buy |
3,446
+18
| +0.5% | +$2.02K | 0.14% | 177 |
|
|
2021
Q1 | $330K | Buy |
3,428
+222
| +7% | +$21.4K | 0.13% | 197 |
|
|
2020
Q4 | $274K | Buy |
3,206
+682
| +27% | +$58.3K | 0.11% | 202 |
|
|
2020
Q3 | $211K | Buy |
+2,524
| New | +$211K | 0.14% | 149 |
|
|
2019
Q4 | – | Sell |
-2,592
| Closed | -$203K | – | 170 |
|
|
2019
Q3 | $203K | Sell |
2,592
-915
| -26% | -$71.7K | 0.21% | 150 |
|
|
2019
Q2 | $216K | Buy |
+3,507
| New | +$216K | 0.24% | 130 |
|